These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15254235)

  • 21. jun-N-terminal kinase regulates thrombin-induced PAI-1 gene expression in proximal tubular epithelial cells.
    Pontrelli P; Ranieri E; Ursi M; Ghosh-Choudhury G; Gesualdo L; Paolo Schena F; Grandaliano G
    Kidney Int; 2004 Jun; 65(6):2249-61. PubMed ID: 15149338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
    Sachsenmaier C; Sadowski HB; Cooper JA
    Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
    Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
    Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
    Garcia R; Yu CL; Hudnall A; Catlett R; Nelson KL; Smithgall T; Fujita DJ; Ethier SP; Jove R
    Cell Growth Differ; 1997 Dec; 8(12):1267-76. PubMed ID: 9419415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
    Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of TLR signalling by the C-terminal Src kinase (Csk) in macrophages.
    Aki D; Mashima R; Saeki K; Minoda Y; Yamauchi M; Yoshimura A
    Genes Cells; 2005 Apr; 10(4):357-68. PubMed ID: 15773898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RACK1 regulates G1/S progression by suppressing Src kinase activity.
    Mamidipudi V; Zhang J; Lee KC; Cartwright CA
    Mol Cell Biol; 2004 Aug; 24(15):6788-98. PubMed ID: 15254245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c-Jun NH(2)-terminal kinase pathway in growth-promoting effect of the G protein-coupled receptor cholecystokinin B receptor: a protein kinase C/Src-dependent-mechanism.
    Dehez S; Bierkamp C; Kowalski-Chauvel A; Daulhac L; Escrieut C; Susini C; Pradayrol L; Fourmy D; Seva C
    Cell Growth Differ; 2002 Aug; 13(8):375-85. PubMed ID: 12193476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
    Sun J; Blaskovich MA; Jove R; Livingston SK; Coppola D; Sebti SM
    Oncogene; 2005 May; 24(20):3236-45. PubMed ID: 15735720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
    Buettner R; Mora LB; Jove R
    Clin Cancer Res; 2002 Apr; 8(4):945-54. PubMed ID: 11948098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative regulation of protease-activated receptor 1-induced Src kinase activity by the association of phosphocaveolin-1 with Csk.
    Lu TL; Kuo FT; Lu TJ; Hsu CY; Fu HW
    Cell Signal; 2006 Nov; 18(11):1977-87. PubMed ID: 16678999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylation within the N- and C-Terminal Domains of Src Regulates Distinct Roles of STAT3-Mediated Tumorigenesis.
    Huang C; Zhang Z; Chen L; Lee HW; Ayrapetov MK; Zhao TC; Hao Y; Gao J; Yang C; Mehta GU; Zhuang Z; Zhang X; Hu G; Chin YE
    Cancer Res; 2018 Jun; 78(11):2825-2838. PubMed ID: 29531159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of JNK by Src during Drosophila development.
    Tateno M; Nishida Y; Adachi-Yamada T
    Science; 2000 Jan; 287(5451):324-7. PubMed ID: 10634792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Csk-deficient boundary cells are eliminated from normal Drosophila epithelia by exclusion, migration, and apoptosis.
    Vidal M; Larson DE; Cagan RL
    Dev Cell; 2006 Jan; 10(1):33-44. PubMed ID: 16399076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differing Src signaling levels have distinct outcomes in Drosophila.
    Vidal M; Warner S; Read R; Cagan RL
    Cancer Res; 2007 Nov; 67(21):10278-85. PubMed ID: 17974969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular and genetic analysis of wound healing in Drosophila larvae.
    Galko MJ; Krasnow MA
    PLoS Biol; 2004 Aug; 2(8):E239. PubMed ID: 15269788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variation analysis of MLP, TFAP2A, and CSK in patients with neural tube defects.
    Klootwijk R; Hol FA; Wu M; Willemen JJ; Groenen P; Hamel B; Straatman H; Steegers-Theunissen RP; Mariman EC; Franke B
    J Med Genet; 2003 Apr; 40(4):e43. PubMed ID: 12676916
    [No Abstract]   [Full Text] [Related]  

  • 40. Drosophila Src regulates anisotropic apical surface growth to control epithelial tube size.
    Nelson KS; Khan Z; Molnár I; Mihály J; Kaschube M; Beitel GJ
    Nat Cell Biol; 2012 Mar; 14(5):518-25. PubMed ID: 22446737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.